Nov 19, 2024, 14:54
Sarcopenia and inflammation predict poorer outcomes in Cancer Immunotherapy
George Vlachogiannis, Executive Editor of Cancer Control at Sage Publishing, shared an article by Enes Ucgul on LinkedIn:
“Sarcopenia and inflammation predict poorer outcomes in cancer immunotherapy.
Monitoring muscle mass and systemic inflammation can help optimize survival strategies for cancer patients.
Paper out in Cancer Control.”
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.
Authors: Enes Ucgul, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54